DICE Therapeutics
clinical response maintained in patients with higher disease burden | DICE Therapeutics
Company
Deck Type
Deck date
March 2023
Slide
42 of 59
Similar slides by DICE Therapeutics
See diffirences between slides (animation)
Results
March 2023
subgroup analysis in patients with pasi dice sonar | DICE Therapeutics
Results
October 2022
a | DICE Therapeutics
Related slides by other companies
Exscientia
Investor Presentation
July 2023
establishing response predictor model | Exscientia
Boundless Bio
IPO
March 2024
projected for patient enrollment to potential clinical and beyond | Boundless Bio
BioAtla
Investor Presentation
November 2022
best response in phase non squamous patients | BioAtla
Kymera
Results
December 2022
to response rate | Kymera
Other recent decks by DICE Therapeutics
See all presentations (4 decks)
Results
March 2023
Investor Presentation
March 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights